Core Points - The company, Heptagon Pharmaceuticals-B, repurchased 400,000 shares on October 17 at a price range of HKD 12.740 to HKD 13.100, totaling HKD 5.1349 million [2] - The stock closed at HKD 12.790 on the same day, reflecting a decline of 4.84%, with a total trading volume of HKD 74.9912 million [2] - Year-to-date, the company has conducted 52 repurchase transactions, acquiring a total of 22.793 million shares for a cumulative amount of HKD 156 million [2] Repurchase Details - On October 17, 2025, the company repurchased 40,000 shares at a maximum price of HKD 13.100 and a minimum price of HKD 12.740, with a total expenditure of HKD 513.49 thousand [2] - The repurchase activity has shown a consistent trend, with multiple transactions occurring throughout the year, indicating a strategic approach to managing share value [3] - The highest recorded repurchase price this year was HKD 15.330 on October 9, while the lowest was HKD 2.270 on January 8 [3]
和铂医药-B(02142.HK)10月17日回购40.00万股，耗资513.49万港元